Crinetics Pharmaceuticals
CRNX
CRNX
71 hedge funds and large institutions have $475M invested in Crinetics Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
62% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 13
Holders
71
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.98M | |
| 2 | +$1.84M | |
| 3 | +$1.81M | |
| 4 |
Goldman Sachs
New York
|
+$1.37M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$892K |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$3.07M | |
| 3 | -$3.06M | |
| 4 |
Morgan Stanley
New York
|
-$2.71M |
| 5 |
Millennium Management
New York
|
-$1.98M |